A Study to Determine the Safety and Efficacy of NT-501 With MHFM
NCT06397131
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Telangiectasia Type 2
Interventions
COMBINATION_PRODUCT:
NT-501 CNTF Implant
Sponsor
Neurotech Pharmaceuticals